Shandong Wandefu Biotechnology Co., Ltd. announced that it will receive CNY 264,817,500 in an equity round of funding on January 12, 2024. The transaction will include participation from returning investor Solbar Ningbo Protein Technology Co., Ltd. for CNY 264,817,500 to retain the majority stake in the company. This has been approved in the 2nd Directorate and the 8th Meeting of the 2nd Supervisory Board of the investor's company.

The registered capital of the company will increase from CNY 55,000,000 to CNY 319,817,500. The transaction does not need the Shareholders? Approval.